BJTR.F Stock Overview
Engages in the manufacture, retail, and wholesale of healthcare products and Chinese medicine to wholesalers and individuals. More details
Snowflake Score | |
---|---|
Valuation | 2/6 |
Future Growth | 3/6 |
Past Performance | 2/6 |
Financial Health | 6/6 |
Dividends | 4/6 |
My Notes
Capture your thoughts, links and company narrative
Beijing Tong Ren Tang Chinese Medicine Company Limited Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | HK$0.65 |
52 Week High | HK$1.50 |
52 Week Low | HK$0.65 |
Beta | 0.38 |
1 Month Change | 0% |
3 Month Change | -56.77% |
1 Year Change | n/a |
3 Year Change | n/a |
5 Year Change | n/a |
Change since IPO | -56.48% |
Recent News & Updates
Recent updates
Shareholder Returns
BJTR.F | US Pharmaceuticals | US Market | |
---|---|---|---|
7D | 0% | 1.6% | -2.2% |
1Y | n/a | 9.7% | 23.9% |
Return vs Industry: Insufficient data to determine how BJTR.F performed against the US Pharmaceuticals industry.
Return vs Market: Insufficient data to determine how BJTR.F performed against the US Market.
Price Volatility
BJTR.F volatility | |
---|---|
BJTR.F Average Weekly Movement | n/a |
Pharmaceuticals Industry Average Movement | 10.4% |
Market Average Movement | 6.3% |
10% most volatile stocks in US Market | 17.0% |
10% least volatile stocks in US Market | 3.1% |
Stable Share Price: BJTR.F's share price has been volatile over the past 3 months.
Volatility Over Time: Insufficient data to determine BJTR.F's volatility change over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1669 | 798 | Wang Chi | www.tongrentangcm.com |
Beijing Tong Ren Tang Chinese Medicine Company Limited, together with its subsidiaries, engages in the manufacture, retail, and wholesale of healthcare products and Chinese medicine to wholesalers and individuals. The company operates through three segments: Hong Kong, Mainland China, and Overseas. It also offers Chinese medical consultation and treatment services.
Beijing Tong Ren Tang Chinese Medicine Company Limited Fundamentals Summary
BJTR.F fundamental statistics | |
---|---|
Market cap | US$965.84m |
Earnings (TTM) | US$69.20m |
Revenue (TTM) | US$195.28m |
14.0x
P/E Ratio4.9x
P/S RatioIs BJTR.F overvalued?
See Fair Value and valuation analysisEarnings & Revenue
BJTR.F income statement (TTM) | |
---|---|
Revenue | HK$1.52b |
Cost of Revenue | HK$477.70m |
Gross Profit | HK$1.05b |
Other Expenses | HK$506.85m |
Earnings | HK$540.39m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
Earnings per share (EPS) | 0.65 |
Gross Margin | 68.67% |
Net Profit Margin | 35.44% |
Debt/Equity Ratio | 0.008% |
How did BJTR.F perform over the long term?
See historical performance and comparisonDividends
3.7%
Current Dividend Yield51%
Payout RatioCompany Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2024/06/29 05:36 |
End of Day Share Price | 2024/04/01 00:00 |
Earnings | 2023/12/31 |
Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Beijing Tong Ren Tang Chinese Medicine Company Limited is covered by 8 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
Yanyin Zhu | China International Capital Corporation Limited |
null null | CMB International Securities Limited |
Christina Chen | HSBC |